Sign up for
patient advisories

Pierre Fabre group, the third largest French pharmaceutical company, has made its Research & Development a key element for its differentiation and a driving force for its growth in the medical field.

Based on a very active partnership policy, the Pierre Fabre Group concentrates its resources on research and development of original molecules, whether natural, chemical or biological for therapeutic uses.

Research and Development, the research conducted within the Pierre Fabre Laboratories concentrates on five strategic areas:

• Oncology
• Central nervous system
• Cardio-vascular diseases
• Immunology applied to the prevention of infectious diseases and anti-cancer therapy
• Dermatology